Site name unknown, Barcelona

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib (DoviGIST)	Completed	Active	Dovitinib	NCT01478373
1	A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors	Completed	Closed	HSP990	NCT00879905